- Patent Title: Medical device alert, optimization, personalization, and escalation
-
Application No.: US18220513Application Date: 2023-07-11
-
Publication No.: US12154427B2Publication Date: 2024-11-26
- Inventor: Mark Gilmore Mears
- Applicant: Roche Diabetes Care, Inc.
- Applicant Address: US IN Indianapolis
- Assignee: Roche Diabetes Care, Inc.
- Current Assignee: Roche Diabetes Care, Inc.
- Current Assignee Address: US IN Indianapolis
- Agency: Flaster Greenberg P.C.
- Main IPC: G06V40/16
- IPC: G06V40/16 ; A61B5/00 ; A61B5/1171 ; A61B5/12 ; G08B3/10 ; G16H10/60 ; G16H40/63 ; G16H50/30 ; H03G3/32 ; H04L67/306 ; H04L67/52 ; A61B5/145

Abstract:
An alert is used to inform a user that their blood glucose level has dropped below a threshold (e.g., the user is hypoglycemic) or has increased above a threshold (e.g., the user is hyperglycemic). There is a hierarchy of alerts from lowest priority to highest priority. The alert is communicated by a user device (e.g., a mobile device), which is, for example, a smartphone, smart watch, home automation device, or the like. The alert is modified in order to increase the likelihood that the user receives or acknowledges the alert within a minimal amount of time. An intensity level (e.g., a volume) of an alert is modified based on, for example, whether the user has acknowledged a previous alert. A modality or a sensory channel of an alert is changed if an initial alert does fails to elicit a response from the user.
Public/Granted literature
- US20230351867A1 MEDICAL DEVICE ALERT, OPTIMIZATION, PERSONALIZATION, AND ESCALATION Public/Granted day:2023-11-02
Information query